• home
  • ICKSH
  • Scientific Program

Scientific Program

  • Thursday, March 30
  • Friday, March 31
  • Saturday, April 1

Thursday, March 30

[CS01] Collaborative Session 01: Innovative diagnostic technologies

Date & Time March 30 (Thursday), 9:00-10:15 Room 1
Chairs TBD
Presentations
  • Single cell sequencing
    Geoffrey McDermott (10x Genomics, Inc., Korea)
  • Blood disease with AI
    Tabe Yoko (Juntendo University, Japan)
  • Discover the Unique Power of Using Droplet Digital PCR (ddPCR) for Hematology-Oncology Applications
    Gina Sun (BioRad, USA)
  • Holotomography and artificial intelligence: label-free 3D imaging, classification, and inference
    YongKeun Park (Tomocube Inc., Korea)

[SS01] Scientific Session 01: Challenging issues in childhood blood disorders

Date & Time March 30 (Thursday), 9:00-10:15 Room 2
Chairs TBD
Presentations
  • How to diagnosis and treat neutropenia in childhood
    Kelly Walkovich (University of Michigan, USA)
  • Updates in the treatment of pediatric relapsed/refractory acute myeloid leukemia
    Keon Hee Yoo (Sungkyunkwan University School of Medicine, Korea)
  • CAR T cells and Acute Lymphoblastic Leukemia: Current State, Challenges and Future Approaches
    Micheal Verneris (University of Colorado School of Medicine, Children’s Hospital Colorado, USA)

[SS02] Scientific Session 02: How far has cell therapy developed in Hodgkin lymphoma?

Date & Time March 30 (Thursday), 9:00-10:15 Room 3
Chairs TBD
Presentations
  • Biological classification of HL by single cell transcriptomics
    Ralf Küppers (University of Duisburg-Essen, Germany)
  • Emerging Cellular therapy in HL
    Natalie S Grover (The University of North Carolina at Chapel Hill, USA)
  • Novel treatment of relapsed/refractory Hodgkin lymphoma
    Hyeon-Seok Eom (National Cancer Center, Korea)

[ES01] Education Session 01: Different treatment goals for overcoming resistance or functional cure in CML

Date & Time March 30 (Thursday), 9:00-10:15 Room 4
Chairs TBD
Presentations
  • Asciminib: the first-in-class allosteric inhibitor of BCR/ABL1 kinase
    Eun-Ji Choi (University of Ulsan College of Medicine, Korea)
  • Treatment after failure of frontline therapy of CML-CP including allo-HSCT
    Jieun Uhm (Hanyang University College of Medicine, Korea)
  • Update on Treatment free remission
    Jae Joon Han (Kyung Hee University College of Medicine, Korea)

[PL01] Plenary Lecture 01

Date & Time March 30 (Thursday), 10:30-11:15 Room 1
Chair TBD
Presentation
  • Regulation of iron metabolism
    Martina U. Muckenthaler (University of Heidelberg, Germany)

[PS01] Presidential Symposium

Date & Time March 30 (Thursday), 11:15-12:00 Room 1
Chairs TBD
Presentation
  • What can Nano do for Medicine?
    Taeghwan Hyeon (Seoul National University, Korea)

[JS01] Asian Hematology Session I (JSM & KMMWP) - Multiple Myeloma

Date & Time March 30 (Thursday), 15:05-16:20 Room 1
Chairs TBD
Presentations
  • Clinical researches on POEMS syndrome in Japan
    Chiaki Nakaseko (International University of Health and Welfare School of Medicine, Japan)
  • Updates on POEMS syndrome in Korea
    Jin Seok Kim (Yonsei University College of Medicine, Korea)
  • Therapeutic approach of Waldenström's macroglobulinemia in Japan
    Hiroshi Handa (Gunma University, Japan)
  • Clinical researches on Waldenström's macroglobulinemia in Korea
    Hosup Lee (Kosin University College of Medicine, Korea)

[SS03] Scientific Session 03: Where we are, in the era of new agents for aplastic anemia?

Date & Time March 30 (Thursday), 15:05-16:20 Room 2
Chairs TBD
Presentations
  • Aplastic Anemia: Current Management Considerations
    Emma M. Groarke (National Institutes of Health, USA)
  • Clinical and molecular factors of clonal evolution in aplastic anemia
    Jaroslaw P. Maciejewski (Cleveland Clinic, USA)
  • TBD
    Jae Wook Lee (The Catholic University of Korea, Korea)

[SS04] Scientific Session 04: How can we approach thrombocytopenia?

Date & Time March 30 (Thursday), 15:05-16:20 Room 3
Chairs TBD
Presentations
  • Diagnosis and treatment of TA-TMA; Current challenge and future strategies
    Rafael Duarte (Institute Catala d'Oncologia, Barcelona, Spain)
  • Genetics of inherited thrombocytopenia
    Kathleen Freson (University of Leuven, Belgium)
  • Advances on pathogenesis and diagnosis of TTP
    Hyun Kyung Kim (Seoul National University College of Medicine, Korea)

[ES02] Education Session 02: How I treat rare lymphomas?

Date & Time March 30 (Thursday), 15:05-16:20 Room 4
Chairs TBD
Presentations
  • Intravascular B-cell lymphoma
    Youngwoo Jeon (The Catholic University of Korea, Korea)
  • T-large granular lymphocytic leukemia
    Jae-Cheol Jo (University of Ulsan College of Medicine, Korea)
  • Lymphomatoid granulomatosis
    Jeong-Ok Lee (Seoul National University Bundang Hospital, Korea)

[CS02] Collaborative Session 02: Innovative therapeutic technologies

Date & Time March 30 (Thursday), 16:35-17:50 Room 1
Chairs TBD
Presentations
  • A Phase 1a Study of BR101801, PI3Kγδ and DNA PK Triple Inhibitor, in Adult Patients with Advanced Hematologic Malignancies
    Bong-Seog Kim (Boryung Co. Ltd., Korea)
  • BGB-11417 the new Bcl-2 inhibitor, the story so far
    David Simpson (BeiGene, Ltd., New Zealand)
  • Bispecific antibody : ABL Bio
    Jonghwa Won (ABL Bio Inc., Korea)
  • T cell-based cellular immunotherapy
    TBD

[SS05] Scientific Session 05: Artificial intelligence application in hematology

Date & Time March 30 (Thursday), 16:35-17:50 Room 2
Chairs TBD
Presentations
  • Artificial intelligence in hematology: basic concepts
    Roni Shouval (Memorial Sloan Kettering Cancer Center, USA)
  • How ML deepens our understanding of hematologic malignancies?
    Valeria Visconte (Cleveland Clinic, USA)
  • Pitfalls of AI for medical application
    Jongmun Choi (Green Cross Genome, Korea)

[SS06] Scientific Session 06: Definding and improving survival of high-risk multiple myeloma

Date & Time March 30 (Thursday), 16:35-17:50 Room 3
Chairs TBD
Presentations
  • Identification of high-risk multiple myeloma
    Niels van de Donk (Amsterdam University Medical Center, The Netherlands)
  • Updated diagnosis and treatment of plasma cell leukemia
    Sung-Hoon Jung (Chonnam National University Hwasun Hospital , Korea)
  • Novel academic BCMA-CART for AL amyloidosis
    Moshe Gatt (The Hebrew University of Jerusalem, Israel)

[ES03] Education Session 03: Rare hematologic malignancies with cutaneous manifestation

Date & Time March 30 (Thursday), 16:35-17:50 Room 4
Chairs TBD
Presentations
  • Sezary syndrome and Mycosis fungoides
    Hyewon Lee (National Cancer Center, Korea)
  • Systemic mastocytosis
    Hyun Jung Lee (Kyung Hee University College of Medicine, Korea)
  • Plasmacytoid dendritic cell neoplasm
    Yoo Jin Lee (University of Ulsan College of Medicine, Korea)

Friday, March 31

[JS02] ASH-KSH Joint Symposium - T Cell Lymphoma

Date & Time March 31 (Friday), 9:00-10:15 Room 1
Chairs TBD
Presentations
  • Clinical Researchers Conducting NK/T cell lymphoma research
    TBD
  • Treatment of extranodal NK/T-cell lymphoma: Korean Lymphoma Working Party experience
    Seok Jin Kim (National Cancer Center, Korea)
  • Clinical Researchers Conducting T-cell lymphoma research
    TBD
  • Treatment of peripheral T-cell lymphoma: Korean Lymphoma Working Party experience
    Deok-Hwan Yang (The Catholic University of Korea, Korea)

[SS07] Scientific Session 07: What is the direction of the new CAR-T therapy?

Date & Time March 31 (Friday), 9:00-10:15 Room 2
Chairs TBD
Presentations
  • Clinical factors affecting survival outcomes after CAR-T cell therapy
    TBD
  • inHouse CAR-T in lymphoma
    Hyoung Jin Kang (Seoul National University College of Medicine, Korea)
  • Updates on the latest developments in CAR-T therapies
    Hiroshi Fujiwara (Mie University, Japan)

[SS08] Scientific Session 08: Comprehensive approaches to understand hemophilia

Date & Time March 31 (Friday), 9:00-10:15 Room 3
Chairs TBD
Presentations
  • Genotyping of Hemophilia, Why We Need it and How We Do?
    Jill Johnsen (University of Washington, USA)
  • Value of National Cohort Registry Data of Hemophilia
    Jung Woo Han (Yonsei University College of Medicine, Korea)
  • Gene Therapy in Hemophilia: Recent Advances & Updates
    TBD

[ES04] Education Session 04: Back to the basic: transfusion support

Date & Time March 31 (Friday), 9:00-10:15 Room 4
Chairs TBD
Presentations
  • Transfusion support for HSCT
    Dong Wook Jekarl (The Catholic University of Korea, Korea)
  • Evidence based transfusion threshold
    Dae-Hyun Ko (University of Ulsan College of Medicine, Korea)
  • Current status of manufactured blood cells
    Eun Jung Baek (Hanyang University College of Medicine, Korea)

[PL02] Plenary Lecture 02

Date & Time March 31 (Friday), 10:30-11:15 Room 1
Chair TBD
Presentation
  • The role of the intestinal microbiome in cancer immunotherapy
    Marcel van den Brink (Memorial Sloan Kettering Cancer Center, USA)

[JS03] International Collaborative Session - Aplastic Anemia

Date & Time March 31 (Friday), 15:05-16:20 Room 1
Chairs TBD
Presentations
  • Overview of AA diagnosis and treatment in NIHBT, VietNam
    Nguyen Thi Thao (National Institute of Hematology and Blood Transfusion, Vietnam)
  • The Incidence and Real-world Outcome of Aplastic Anemia in Thailand
    Lalita Norasetthada (Maharaj Nakorn Chiengmai , Thailand)
  • Role of TPO receptor agonists in aplastic anemia treatment
    Jun Ho Jang (Samsung Medical Center, Korea)

[SS09] Scientific Session 09: Which immune therapy is our future weapon against AML?

Date & Time March 31 (Friday), 15:05-16:20 Room 2
Chairs TBD
Presentations
  • DART therapy for AML
    Sergio Rutella (John van Geest Cancer Research Centre, UK)
  • Determining the barriers to successful CAR T cell therapy for AML
    Miriam Y Kim (University of Washington, USA)
  • Adoptive T cell transfer of three universal tumor associated antigens-specific T cells for the treatment of AML
    Byung Sik Cho (The Catholic University of Korea, Korea)

[SS10] Scientific Session 10: Advanced technologies in cytogenetics and molecular genetics

Date & Time March 31 (Friday), 15:05-16:20 Room 3
Chairs TBD
Presentations
  • Whole-transcriptome analysis in ALL
    TBD
  • Whole genome sequencing of fluorescence in situ hybridized cells in hematologic malignancies using SLACS
    Sunghoon Kwon (Seoul National University, Korea)
  • Next generation cytogenetics – optical mapping for comprehensive structural variant detection in hematological malignancies and beyond
    Alexander Hoischen (Chonnam National University Medical School, Korea)

[ES05] Education Session 05: Practical issue in CAR-T

Date & Time March 31 (Friday), 15:05-16:20 Room 4
Chairs TBD
Presentations
  • Setting up the facility for CAR T cell therapy
    Ja Min Byun (Seoul National University College of Medicine, Korea)
  • Technical aspect of manufacturing CAR T cell product
    Jong-Seo Lee (AbClon Inc., Korea)
  • Managing adverse events of CAR T cell therapy
    Jae Won Yoo (The Catholic University of Korea, Korea)

[JS04] EHA-KSH Joint Symposium - Myelodysplastic Syndrome

Date & Time March 31 (Friday), 16:35-17:50 Room 1
Chairs TBD
Presentations
  • MDS 2023: standards and perspectives
    Uwe Platzbecker (Leipzig University Hospital, Germany)
  • Treatment of MDS: Korean AML/MDS working party experience
    June-Won Cheong (Yonsei University College of Medicine, Korea)
  • TBD
    Lionel Adès (Co-chair of the SWG MDS, France)
  • Genetic alteration in MDS
    Yoo-Jin Kim (The Catholic University of Korea, Korea)

[SS11] Scientific Session 11: Liquid biopsy application in hematology

Date & Time March 31 (Friday), 16:35-17:50 Room 2
Chairs TBD
Presentations
  • Cell-free DNA profiling for monitoring of complications of hematopoietic cell transplantation
    Iwijn De Vlaminck (Cornell University, USA)
  • Microbial cell-free DNA sequencing to predict bloodstream infection in pediatric cancer patients
    Charles Gawad (St. Jude Children's Research Hospital, USA)
  • Clinical applications of circulating tumor DNA analysis in lymphoma
    Seung-Tae Lee (Yonsei University College of Medicine, Korea)

[SS12] Scientific Session 12: Up-to-date diagnostic and treatment strategies of adult ALL patients

Date & Time March 31 (Friday), 16:35-17:50 Room 3
Chairs TBD
Presentations
  • Are we moving towards a chemo- and transplant-free management of Ph-positive adult ALL?
    Robin Foa (Sapienza University of Rome, Italy)
  • Development of more-effective CAR T-cell therapy for ALL
    Saar I Gill (University of Pennsylvania School of Medicine, USA)
  • Overcoming high-risk features in adult ALL patients
    Jae-Ho Yoon (The Catholic University of Korea, Korea)

Saturday, April 1

[JS05] Asian Hematology Session II - Red Blood Cell Disorder

Date & Time April 1 (Saturday), 9:00-10:15 Room 1
Chairs TBD
Presentations
  • Overview of Thalassaemia and Hemoglobinopathies in Bangladesh
    Mahmood A. Chowdhury (Chattogram Maa-O-Shishu Hospital Medical College, Bangladesh)
  • Current Situation of Thalassemia Care in Cambodia
    Chean Sophal (National Pediatric Hospital, Cambodia)
  • Epidemiology and diagnosis of hemolytic anemia in Korea
    Heewon Chueh (Dong-A University College of Medicine, Korea)

[SS13] Scientific Session 13: Current knowledge of human hematopoietic stem cell

Date & Time April 1 (Saturday), 9:00-10:15 Room 2
Chairs TBD/td>
Presentations
  • Single cell HSPC map
    William J. Greenleaf (Stanford University, USA)
  • Humanized Mouse and Non-human Primates: Animal Models for HSC Research
    Kyung-Rok Yu (Seoul National University, Korea)
  • What we know about HSC homing?
    Xinxin Huang (Fudan University, China)

[SS14] Scientific Session 14: What's new in chronic lymphocytic leukemia?

Date & Time April 1 (Saturday), 9:00-10:15 Room 3
Chairs TBD
Presentations
  • Patient selection for time limited versus continued therapy
    Jennifer R. Brown (Dana-Farber Cancer Institute, USA)
  • Translating scientific advances in CLL
    Richard Rosenquist (Karolinska Institute, Sweden)
  • MRD monitoring in CLL Patients
    Ki-Seong Eom (The Catholic University of Korea, Korea)

[ES06] Education Session 06: Novel therapeutics for myeloproliferative neoplasms

Date & Time April 1 (Saturday), 9:00-10:15 Room 4
Chairs TBD
Presentations
  • Prognostication in MPNs (including mutation abnormalities)
    Junshik Hong (Seoul National University Hospital, Korea)
  • Novel Therapeutics for MF (including cyotpenic myelofibrosis)
    Sung-Eun Lee (The Catholic University of Korea, Korea)
  • Novel Therapeutics for ET/PV
    Seugyun Yoon (Soonchunhyang University Seoul Hospital, Korea)

[PL03] Plenary Lecture 03

Date & Time April 1 (Saturday), 10:30-11:15 Room 1
Chairs TBD
Presentation
  • Recent advance in the hematopoietic stem cell research
    Toshio Suda (National University of Singapore, Singapore)
Organized by
Supported by